BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5820060)

  • 1. Contraception by an injectable, long-acting oestrogen-progestogen agent.
    Plesner R
    Acta Endocrinol (Copenh); 1969 Jul; 61(3):494-508. PubMed ID: 5820060
    [No Abstract]   [Full Text] [Related]  

  • 2. Contraception by an injectable long-acting oestrogen-progestogen agent. 3. Effects on the excretion of total pituitary gonadotropins, on ovulation and on the endometrium.
    Plesner R
    Acta Endocrinol (Copenh); 1972 Jan; 69(1):67-76. PubMed ID: 5067036
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic patterns of gonadotrophin, pregnanediol, and corticoid excretion in women on long-term oral contraceptive therapy.
    Roland M; Paulson SR; Knudsen KA; Laurie RE; Edgren RA
    Fertil Steril; 1971 Jul; 22(7):416-23. PubMed ID: 5556748
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of ovarian effectors, pregnanediol, gonadotrophins, 17-ketosteroids, 17-hydroxysteroids, and proteic iodine, during therapy with clomiphene.
    Ruiz-Velasco V; Arceo JR; Villanueva Gasca A
    Int J Fertil; 1970; 15(4):214-20. PubMed ID: 4098880
    [No Abstract]   [Full Text] [Related]  

  • 5. Wy 3707, a totally synthesized progestogen for contraception.
    Roland M
    Int J Fertil; 1966; 11(4):401-4. PubMed ID: 5970362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ovulation inhibitors and ACTH reserve].
    Rindt W; Heinen G; Oertel GW
    Endokrinologie; 1971 Apr; 57(3):358-63. PubMed ID: 4325995
    [No Abstract]   [Full Text] [Related]  

  • 7. [Luteal function during treatment with chlormadinone in low doses].
    Geller S; Scholler R
    Pathol Biol (Paris); 1971 Feb; 19(3):157-65. PubMed ID: 4100967
    [No Abstract]   [Full Text] [Related]  

  • 8. [Theoretic principles of hormonal contraception].
    Hammerstein J
    Med Klin; 1970 Jul; 65(27):1279-89. PubMed ID: 4931202
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution on the therapy of anovulatory sterility with menopausal gonadotropin].
    Stöckli A
    Gynaecologia; 1969; 167(5):439-42. PubMed ID: 5802923
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical testing of antinidation effect of ergocornine methanesulfonate].
    Stĕrba R
    Zentralbl Gynakol; 1968 Mar; 90(9):311-4. PubMed ID: 5713223
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversed sequential therapy of hirsutism using cyproterone acetate. II. Hormonal analyses.
    Zielske F; Dreykluft R; Magnus U; Hammerstein J
    Acta Endocrinol Suppl (Copenh); 1971; 152():15. PubMed ID: 5313533
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian sensitivity to human gonadotrophins in women with amenorrhoea after oral contraceptive treatment.
    Nillius SJ; Gemzell C
    Acta Endocrinol (Copenh); 1972 Mar; 69(3):445-58. PubMed ID: 5067011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of Ro 4-8347 administered from the 5th to 25th of the cycle to women with regular cycle with ovulation].
    Guéguen J
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):428-40. PubMed ID: 5510169
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new combined test of ovarian inhibition and adrenal stimulation: behavior of urinary total and fractionated 17-KS, of 17-hydroxycorticoids, pregnanediol and pregnanetriol].
    Bellastella A; D'Alessandro B; Gasbarro R; Iacono G
    Folia Endocrinol; 1969 Dec; 22(4):498-504. PubMed ID: 4329094
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism in inhibition of ovulation in oral contraception. 3. The excretion of total pituitary gonadotrophins and luteinizing hormone in fertile women during cyclical treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone together with 17-alpha-ethynyl-oestradinol-3-methylether.
    Starup J; Lebech PE
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):188-96. PubMed ID: 6072686
    [No Abstract]   [Full Text] [Related]  

  • 16. [Risks of ovarian overstimulation by administration of clomiphene and gonadotropins for ovulation stimulation].
    Hammerstein J
    Geburtshilfe Frauenheilkd; 1967 Dec; 27(12):1125-51. PubMed ID: 5627491
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormones and schizophrenia].
    Brambilla F; Cazzulo CL; Penati G
    Probl Actuels Endocrinol Nutr; 1974; Serie 18():273-97. PubMed ID: 4377918
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of ethinylestrenol and mestranol as a contraceptive.
    Kaltreider DF
    Fertil Steril; 1968; 19(4):589-92. PubMed ID: 5660243
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pituitary-adrenocortical function of women following Gestagen administration].
    Yagi T
    Nihon Naibunpi Gakkai Zasshi; 1967 Jan; 42(10):1098-116. PubMed ID: 4291682
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of microdose norgestrel on endogenous gonadotropic and steroid hormones, cervical mucus properties, vaginal cytology, and endometrium.
    Moghissi KS; Marks C
    Fertil Steril; 1971 Jul; 22(7):424-34. PubMed ID: 5104921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.